Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Voß, Martin ^a   Bischof, Felix ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; FLUDARABINE; HYDROXYUREA; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OLIGOCLONAL BAND; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; NEUROPROTECTIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CHRONIC MYELOMONOCYTIC LEUKEMIA; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT VERSUS HOST REACTION; HUMAN; HYPESTHESIA; LIMB WEAKNESS; MALE; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; PARESTHESIA; PROTEIN CEREBROSPINAL FLUID LEVEL; REFLEX DISORDER; THORACIC SPINAL CORD; URINARY DYSFUNCTION; WHOLE BODY RADIATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; VERTEBRA;

AGED; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MYELITIS; NEUROPROTECTIVE AGENTS; RECURRENCE; THORACIC VERTEBRAE;

EID: 79952112848     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-76     Document Type: Article

References (6)

1. Denier C, Bourhis JH, Lacroix C, Koscielny S, Bosq J, Sigal R, Said G, Adams D. Spectrum and prognosis of neurologic complications after hematopoietic transplantation. Neurology 2006, 67:1990-7. 10.1212/01.wnl.0000247038.43228.17, 17159106.
2. Saiz A, Graus F. Neurological complications of hematopoietic cell transplantation. Semin Neurol 2004, 24:427-34. 10.1055/s-2004-861537, 15637654.
3. de Lima M, Couriel D, Thall PF, Wang X, Madden T, Jones R, Shpall EJ, Shahjahan M, Pierre B, Giralt S, et al. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood 2004, 104:857-64. 10.1182/blood-2004-02-0414, 15073038.
4. Airas L, Paivarinta M, Roytta M, Karhu J, Kauppila M, Itala-Remes M, Remes K. Central nervous system immune reconstitution inflammatory syndrome (IRIS) after hematopoietic SCT. Bone Marrow Transplant 2010, 45:593-6. 10.1038/bmt.2009.186, 19684631.
5. Rosser AE, Zietlow R, Dunnett SB. Stem cell transplantation for neurodegenerative diseases. Curr Opin Neurol 2007, 20:688-92. 10.1097/WCO.0b013e3282f132fc, 17992090.
6. Mondria T, Lamers CH, te Boekhorst PA, Gratama JW, Hintzen RQ. Bone-marrow transplantation fails to halt intrathecal lymphocyte activation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008, 79:1013-5. 10.1136/jnnp.2007.133520, 18223013.